Recent findings suggested that the complex crosstalk between the PI3K/AKT/mTOR pathway and multiple interacting cellular signaling cascades could further promote the progression of PCa and influenced the sensitivity of PCa cells to PI3K/AKT/mTOR-targeted therapies being explored clinically (Shorning et al., 2020). The gene discussed is AKT1; the disease is posterior cortical atrophy.